[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588255":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":25,"centralContacts":33,"locations":39,"responsibleParty":55,"collaborators":58,"id":73,"slug":22,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":74,"sex":80,"minAge":81,"maxAge":22,"enrollmentInfo":82,"targetDuration":22,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":100,"overallStatus":41,"whyStopped":22,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","OTHER",[8,13],{"label":9,"type":10,"description":9,"interventionNames":11},"Laparoscopic minimally invasive left-sided pancreatecomy","ACTIVE_COMPARATOR",[12],"Procedure: Laparoscopic minimally invasive left-sided pancreatecomy",{"label":14,"type":15,"description":14,"interventionNames":16},"Robot-assisted minimally invasive left-sided pancreatecomy","EXPERIMENTAL",[17],"Procedure: Robot-assisted minimally invasive left-sided pancreatecomy",[19,23],{"type":20,"name":9,"description":9,"armGroupLabels":21,"otherNames":22},"PROCEDURE",[9],null,{"type":20,"name":14,"description":14,"armGroupLabels":24,"otherNames":22},[14],[26,30],{"name":27,"affiliation":28,"role":29},"Prof. Mohammad Abu Hilal, MD PhD","University of Jordan","PRINCIPAL_INVESTIGATOR",{"name":31,"affiliation":32,"role":29},"Prof. Marc Besselink, MD, PhD","Amsterdam UMC",[34],{"name":35,"role":36,"phone":37,"phoneExt":22,"email":38},"Charlotte Baggerman van Houweninge, MD","CONTACT","+31618037377","c.e.baggermanvanhouweninge@amsterdamUMC.nl",[40],{"facility":32,"status":41,"city":42,"state":22,"zip":22,"country":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Amsterdam","Netherlands",{"type":45,"coordinates":46},"Point",[47,48],4.88969,52.37403,{"lat":48,"lon":47},[51],{"name":52,"role":36,"phone":53,"phoneExt":22,"email":54},"Besselink","0031618037377","c.e.baggermanvanhouweninge@amsterdamumc.nl",{"type":29,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":22,"oldOrganization":22},"M.G. Besselink","prof. dr. M.G. Besselink",[59,61,63,65,67,69,71],{"name":60,"class":6},"Leiden University Medical Center",{"name":62,"class":6},"Catharina Ziekenhuis Eindhoven",{"name":64,"class":6},"Erasmus Medical Center",{"name":66,"class":6},"Medisch Spectrum Twente",{"name":68,"class":6},"Maastricht University Medical Center",{"name":70,"class":6},"University Medical Center Groningen",{"name":72,"class":6},"Onze Lieve Vrouwe Gasthuis","100588255",false,"NCT06939023","Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)","Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3): an International Multicenter Patient-blinded Randomized Controlled Trial","DIPLOMA-3","Inclusion Criteria:\n\n* Age at least 18 years;\n* Indication for elective left-sided pancreatectomy, either spleen-preserving or non-preserving (because of proven or suspected left-sided benign or premalignant disease);\n* Both robot-assisted and laparoscopic left-sided pancreatectomy are technically feasible for resection, according to the local treatment team;\n* Fit to undergo left-sided pancreatectomy according to the surgeon and anaesthesiologist;\n* Written informed consent\n\nExclusion Criteria:\n\n* Suspected pancreatic ductal adenocarcinoma;\n* Tumor or cyst larger than 8 cm;\n* Required resection or ablation of organs other than pancreas and spleen;\n* Tumor involvement or abutment of major vessels (celiac trunk, mesenteric artery or vena cava);\n* Pregnancy;\n* Body mass index \\>40 kg\u002Fm2;\n* Participation in another study with interference of study outcomes","ALL","18 Years",{"count":83,"type":84},256,"ESTIMATED","INTERVENTIONAL",[87],"NA","The DIPLOMA-3 trial is an international, multicenter, patient-blinded randomized controlled trial comparing laparoscopic and robot-assisted left-sided pancreatectomy. Patients with an indication for elective left-sided pancreatecomy for benign or premalignant lesions in the body or tail of the pancreas and considered eligible will be randomized between laparoscopic and robot-assisted resection.",[90,91,92,93,94,95,96,97,98,99],"Pancreatectomy","Distal Pancreatectomy (DP)","Pancreatic Neoplasms","Pancreatic Adenoma","Pancreatic Cyst","Pancreatic Cystadenoma","Surgery","Minimally Invasive Surgical Technique","Minimally Invasive Distal Pancreatectomy","Minimally Invasive Surgery",[101,102,103,104,105,106,107,108],"pancreas surgery","left-sided pancreatectomy","distal pancreatectomy","minimally invasive surgery","robot-assisted pancreatectomy","left pancreatectomy","robotic pancreatectomy","laparoscopic pancreatectomy","2025-08-28",{"date":111,"type":112},"2025-09-04","ACTUAL",{"date":114,"type":112},"2025-06-01",{"date":116,"type":84},"2028-06-01",{"name":5,"class":6},1]